Literature DB >> 12062558

Immunisation of mice against neosporosis.

Anna Lundén1, Stephen Wright, Judith E Allen, David Buxton.   

Abstract

In the present study a murine encephalitis model was used to investigate if protection against neosporosis could be achieved by immunisation. Groups of 10 mice were immunised with a sublethal dose of live Neospora caninum tachyzoites, N. caninum antigens incorporated into iscoms, N. caninum lysate mixed with Quil A, or N. caninum lysate in PBS. Control mice were given Quil A only. Challenge infection with 2.5x10(6) N. caninum tachyzoites resulted in clinical symptoms that remained until the end of the experiment in the controls. In contrast, mice immunised with live parasites or parasite lysate in Quil A only showed mild and transient symptoms. Of nine mice immunised with N. caninum iscoms, seven recovered while two died. Most severely affected were the mice immunised with parasite lysate only; all of them died within 28 days post-infection. Histological examination and scoring of brain lesions gave a significantly lower (P<0.0001) lesion score in mice immunised with live parasites than in controls. The groups immunised with iscoms or lysate and Quil A also had reduced lesion scores (P<0.04 and 0.07, respectively) but not the group given parasite lysate alone. The lesions seen in the latter group differed from those in the other groups. There was less cellular reaction and more tachyzoites indicating an active infection. The N. caninum specific antibody responses and cytokine production (IFN-gamma, IL-4 and IL-5) of splenocytes were analysed at the time of challenge infection. The results suggest a correlation between protection and high levels of IFN-gamma. Also, the immune responses recorded in mice immunised with parasite lysate without adjuvant were relatively weak and more towards the Th2 type, when compared with the other immunisation schedules. This is consistent with the weaker inflammatory response observed in the brains of these mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062558     DOI: 10.1016/s0020-7519(02)00024-3

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  10 in total

1.  Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract.

Authors:  Pedro Ferreirinha; Joana Dias; Alexandra Correia; Begoña Pérez-Cabezas; Carlos Santos; Luzia Teixeira; Adília Ribeiro; António Rocha; Manuel Vilanova
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

2.  Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain.

Authors:  Diana Marcela Penarete-Vargas; Marie Noelle Mévélec; Sarah Dion; Edouard Sèche; Isabelle Dimier-Poisson; Thierry Fandeur
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

3.  Characterization of tissue distribution and histopathological lesions in Neospora caninum experimentally infected gerbils.

Authors:  Seung-Won Kang; Sung-Soo Park; Se-Eun Choe; Young-Hwa Jean; Suk-Chan Jung; Keun Kim; Dong Van Quyen
Journal:  Parasitol Res       Date:  2009-01-27       Impact factor: 2.289

4.  Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites.

Authors:  Luzia Teixeira; Andreia Marques; Carla Sofia Meireles; Ana Rita Seabra; Diana Rodrigues; Pedro Madureira; Augusto M R Faustino; Carolina Silva; Adília Ribeiro; Paula Ferreira; José Manuel Correia da Costa; Nuno Canada; Manuel Vilanova
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

5.  Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice.

Authors:  Yoshifumi Nishikawa; Houshuang Zhang; Yuzuru Ikehara; Naoya Kojima; Xuenan Xuan; Naoaki Yokoyama
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

Review 6.  Vaccines against a Major Cause of Abortion in Cattle, Neospora caninum Infection.

Authors:  Thierry Monney; Karim Debache; Andrew Hemphill
Journal:  Animals (Basel)       Date:  2011-09-08       Impact factor: 2.752

7.  Adjuvant and immunostimulatory effects of a D-galactose-binding lectin from Synadenium carinatum latex (ScLL) in the mouse model of vaccination against neosporosis.

Authors:  Mariana R D Cardoso; Caroline M Mota; Dâmaso P Ribeiro; Pablo G Noleto; William B F Andrade; Maria A Souza; Neide M Silva; Tiago W P Mineo; José R Mineo; Deise A O Silva
Journal:  Vet Res       Date:  2012-10-29       Impact factor: 3.683

8.  Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice.

Authors:  Silvia Rojo-Montejo; Esther Collantes-Fernández; Inmaculada López-Pérez; Verónica Risco-Castillo; Antoni Prenafeta; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2012-08-22       Impact factor: 3.683

9.  Differential Effects on Survival, Humoral Immune Responses and Brain Lesions in Inbred BALB/C, CBA/CA, and C57BL/6 Mice Experimentally Infected with Neospora caninum Tachyzoites.

Authors:  Tanja Mols-Vorstermans; Andrew Hemphill; Thierry Monney; Dick Schaap; Eveline Boerhout
Journal:  ISRN Parasitol       Date:  2013-03-24

10.  The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite Neospora caninum and Re-infected During Pregnancy.

Authors:  Pablo Winzer; Dennis Imhof; Nicoleta Anghel; Dominic Ritler; Joachim Müller; Ghalia Boubaker; Adriana Aguado-Martinez; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C VanVoorhis; Andrew Hemphill
Journal:  Front Vet Sci       Date:  2020-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.